| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |